highly effective cancer vaccine will indeed be the Holy Grail of both pharma and investors.
better way to think about it. does INO have enough in the pipeline to support a $2 billion market cap ($10 share)? I think so. If trial data are good, can they justify $4 Billion ($20 share). Again I think so. multiple candidates moving toward Phase III approval, with VGX 3100 already approved...(triple digits)
EPS is irrelevant at this point. The question is whether the science is progressing and how soon we know.
manufacturing costs will be under 10% of sales, three dozen salesmen cost $5-10 million per year. So if there is $1 billion in revenues, that leaves $890 million as a contribution to the bottom line. I can live with that.
Rooting to se a traitor prez kicked in the balls is not treason, it is patriotism. Funny to see a liberal talking about treason since the essence of socialist liberalism is treason to the core American values and Constitution that made this country great.
This is not ice hockey, idiot. What we are reaping is the fruits of 10 years of democraps undermining US foreign policy, and especially President Mendacious' demagoguing of an strong American response. Syria was the final test. After Obama folded his cards there after bluffing, President Putin knew he was dealing with a scared, weak leader who was all bluster and no action. Crimea was was easy and low risk after that/
All they had to do was get the stock to $10 and shareholders would have given them what they want. As I tell my kids, no dessert before dinner.
That will be our Twitter moment, when we surpass their $30 billion market cap
a sixty multiple based on this one product, but even bigger HIV, flu, malaria and cancer products in the pipeline. $300 seems quite possible
INO;s tech is one giant leap for mankind!
Be glad you don't get MSNBC, the Goebbels network of the Obama regime
blatant shameless pumping...I like it
volume is about 1/3 of normal so your thesis that this message board is causing a selloff is bogus. technically, this stock is behaving normally for a stock with no news.
What this post tells me is that whatever the results or setbacks of any individual trial, DNA vaccines are clearly seen as the future by a broad swath of the medical/scientific community. This science will be developed, perfected and commercialized, with INO the leading firm in the field. $$$$$
yes, and the research partners are top notch, medical schools in Maryland and NJ, Duke University. It's as if you want to do research in this area, you call INO to work with you. Super!
The bashers (as opposed to ONCS board members) are engaging in loathsome, ad hominem, racist, anti-Korean-American bashing of Dr. Kim. Beyond disgusting! Dr. Kim is a great American and a role model for my teenagers on what real achievement looks like, in contrast to phony celebrity most teenagers try to emulate. I tell them if they work hard like Dr. Kim they could start their own biotech company some day (they are already blessed with the brains), help people and get rich in the process through taking advantage of the opportunities of the American capitalist system.
the shame is getting this deal done and doubling the stock price is exactly the thing that would make shareholders consider rewarding management with stock or options. mgt is being shortsighted, because if this stock could get some good notice, it would far, far more than double. better to ride a $10 stock to $30 than sit mired at under $5 fighting with shareholders and scaring off big investors.